Overview of Short-Term and Long-Term Safety of Brexpiprazole in Patients with Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

By  

Current Psychiatry Reviews, Vol. 12, Iss. 3, 2016-12 ,pp. : 278-290

Bentham Science Publishers

Access to resources Recommend Favorite

Anticonvulsants in the Treatment of Major Depressive Disorder: An Overview

By Vigo Daniel   Baldessarini Ross  

Harvard Review of Psychiatry, Vol. 17, Iss. 4, 2009-08 ,pp. : 231-241

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Predictors of depressive symptoms at hospital discharge in patients with major depressive disorder

By Wedig Michelle M.  

Primary Care Psychiatry, Vol. 17, Iss. 2, 2013-06 ,pp. : 144-147

Informa Healthcare

Access to resources Recommend Favorite

Predictors of depressive symptoms at hospital discharge in patients with major depressive disorder

By Wedig Michelle M.   Weinstock Lauren M.   Epstein-Lubow Gary   Miller Ivan W.  

International Journal of Psychiatry in Clinical Practice, Vol. 17, Iss. 2, 2013-06 ,pp. : 144-147

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder

By Kamath Jayesh   DeMartinis Nicholas   Handratta Venkatesh  

Future Neurology, Vol. 2, Iss. 4, 2007-07 ,pp. : 361-371

Future Medicine

Access to resources Recommend Favorite